Clinical Trial Update: Effect of Talactoferrin in Adults With Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This document reports on a Phase 1 trial of talactoferrin in adults with non-small cell lung cancer, and notes that the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Talactoferrin (talactoferrin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: COMPLETED